This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (24)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurotoxicology  • Dermatology  • Sweating  • Facial Plastic Surgery  • Cosmetic Surgery/ Procedures  • Alert me on articles by topic  Social Bookmarking   What's this?

Markus Naumann, MD; Wolfgang H. Jost, MD; Klaus V. Toyka, MD

Arch Neurol. 1999;56:914-916.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Botulinum neurotoxin A (BoNT/A) has become a valuable tool in the treatment of neurological disorders associated with increased muscle tone and has revolutionized the treatment of dystonia and focal spasticity. It acts at cholinergic nerve terminals by cleaving SNAP-25, a protein involved in the fusion of synaptic vesicles with the presynaptic membrane.¹ Cholinergic autonomic parasympathetic and postganglionic sympathetic nerve synapses are also amenable to treatment with botulinum toxin.

Within the last few years, an increasing number of articles have been published focusing on new applications for BoNT/A. This short review gives an overview on recent indications of BoNT/A in the treatment of disorders of the autonomic nervous system and an outlook on possible future application.

TREATMENT OF AUTONOMIC DISORDERS

In view of the restricted action on the cholinergic system, potential indications for BoNT/A in disorders of the autonomic nervous system include diseases associated . . . [Full Text of this Article]

SUDOMOTOR AND SECRETOMOTOR HYPERACTIVITY

URINARY BLADDER DYSFUNCTION

GASTROINTESTINAL AND OTHER RARE INDICATIONS

CONCLUSIONS

From the Departments of Neurology, Bayerische Julius-Maximilians-Universität, Würzburg (Drs Naumann and Toyka), and Deutsche Klinik für Diagnostik, Wiesbaden (Dr Jost), Germany.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(8):1037-1038.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Myriad Uses of Botulinum Toxin
Pullman
ANN INTERN MED 2005;143:838-839.
FULL TEXT  

Botulinum toxin in clinical practice
Jankovic
J. Neurol. Neurosurg. Psychiatry 2004;75:951-957.
ABSTRACT | FULL TEXT  

Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye
Horwath-Winter et al.
Br J Ophthalmol 2003;87:54-56.
ABSTRACT | FULL TEXT  

Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis
Giess et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:121-123.
ABSTRACT | FULL TEXT  

Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the "sausage poison"
Erbguth and Naumann
Neurology 1999;53:1850-1850.
FULL TEXT